What happened with reshape and vyome?

Simultaneously with the execution of the merger agreement, ReShape, Vyome, and Vyome’s wholly-owned subsidiary, Vyome Therapeutics Ltd., entered into agreements with certain existing accredited investors, pursuant to which the investors have committed to purchase a minimum of $7.3 million in securities of ReShape, Vyome and Vyome’s subsidiary.

How did reshape acquire Biorad MedISys?

Simultaneously with the execution of the merger agreement, ReShape entered into an asset purchase agreement to sell substantially all of its assets to Biorad Medisys, Pvt. Ltd. for a purchase price of $5.16 million in cash.

What are reshape's assets & liabilities?

The assets include ReShape's Lap-Band System, Obalon Gastric Balloon System and the Diabetes Bloc-Stim Neuromodulation (DBSN) System. Biorad will also assume substantially all of ReShape's liabilities.